Paul Morgan

In a note dated June 26, MLV & Co. analyst Paul Morgan initiated coverage on the Healthcare REIT Sector with a neutral view due to the balance of "attractive investment opportunities" and risks from a "rising interest rate environment." Within the sector, Morgan says...

In a report published Tuesday, MLV & Co analyst Paul Morgan initiated coverage on AmREIT (NYSE: AMRE) with a Buy rating and $21.00 price target. In the report, MLV & Co noted, “AmREIT's ‘Irreplaceable Corner' shopping center investment strategy targets high-traffic, infill assets located...